NCBI PubMed Central
open access
Clinical, molecular, and immunologic determinants of survival in WHO-defined IDH-wildtype glioblastoma treated with radiotherapy: a large real-world cohort study.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Molecular Genetic, Host-derived and Clinical Determinants of Long-term Survival in Glioblastoma#991836
- Glioblastoma: epidemiology, molecular pathogenesis, diagnosis, management, and therapeutic resistance.#170593
- Radiogenomic and Prognosis Analysis in Glioma#831106
- Deciphering the glioblastoma microenvironmental landscape with multi-modal radiogenomics to guide prognosis and personalized therapy.#244247
- Nested cross-validation reveals performance inflation in MRI radiomics for early mortality prediction in IDH-wildtype glioblastoma#1106629
Record · ID 135750
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive